Takeda Pharmaceutical Co. Ltd., 10% Owner at Phathom Pharmaceuticals, Inc. (PHAT), sold 14,074 shares at $35.14 ($495K) on 2021-05-05, disclosed to the SEC on 2021-05-07.
Open-market sale of $495k PHAT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.14 | 6,936 | $244K | 49.3% |
| 2 | $35.14 | 6,936 | $244K | 49.3% |
| 3 | $35.01 | 202 | $7K | 1.4% |
| Total | $35.14 avg | 14,074 | $495K | 100% |
| Filing → |
| DAWN | SELL | 2021-12-09 | $9.9M | — | Filing → |
| PHAT | SELL | 2021-11-08 | $20.9M | — | Filing → |
| PHAT | SELL | 2021-07-09 | $183K | — | Filing → |